Ilika plc Launch Solid-state batteries enabling miniaturisation in MedTech

Ilika Plc

Ilika plc (LON: IKA), a pioneer in solid-state battery technology, announced today the launch of Stereax® M50 mm-scale solid-state batteries designed for medical implants. The Stereax M50 takes solid-state batteries to a new level of miniaturisation enabling medical device innovations that have previously been limited by the available battery technology.

Mike Nagy, Chief Technology Officer of Endotronix, which develops Hemodynamic Monitoring Solutions where Ilika’s technology could be applied, said:

“The implantable medical device industry has a growing need for miniaturised, long-life power sources to enable wireless data transfer from increasingly sophisticated devices that are improving patients’ lives.”

The ‘MedTech’ space is one of the most challenging environments for battery technologies. Batteries need to be small enough to be unobtrusive, enabling implantable devices to be charged in a way that does not restrict a patient, and have a long a life-span as possible, avoiding the risks associated with repeated surgical procedures. They also need to be biocompatible so that they do not pose a risk to the patient. Each device application may require different capacities and form factors, which can now be accommodated with the customisable battery sizes and shapes enabled by the Stereax M50. Innovation in applications that require injection into the blood stream, monitoring heart rhythm or attachment onto the peripheral nervous system for neurostimulation can be enabled with this technology. These batteries enable self-sustaining power sources that do not need to be changed regularly or use inconvenient cabling.

Relative to standard lithium ion batteries, Stereax M50 solid-state batteries have longer life spans of up to 10 years (up to 5x longer) and lower leakage currents (10x smaller), making them suitable for low power wireless charging. They can also be integrated with other electronic components enabling the end medical device to be kept as small as possible. Stereax M50 yields leading edge energy density with 50% extra density compared to other commercially available solid-state batteries.

Graeme Purdy, CEO, Ilika plc said:

“The Stereax product family continues to grow, addressing a wide range of end applications. Medical applications are some of the most demanding environments for battery technology. The Stereax M50 is a smaller, safer and longer lasting battery, opening up the opportunities of life enhancing medical devices.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately ÂŁ1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Defence battery demand highlights strategic opening for Ilika

Ilika highlights how rising defence and energy security demands are expanding the commercial opportunity for advanced battery technologies across military and infrastructure markets.

Search